Phil Inter Pharma USA is a company based in Southern California, specializing in softgel contract manufacturing for a variety of dietary supplements. Established in 2012, the company has built a reputation for its unwavering commitment to producing high-quality softgel products and ensuring on-time delivery. The company operates within the Manufacturing, Pharmaceutical, and Marketing industries, positioning itself as a key player in these sectors. Despite the absence of specifics regarding the headquarter location and details of the last investment and investors, Phil Inter Pharma USA's focus on serving the dietary supplement market through its manufacturing expertise positions it as a potential investment opportunity within the pharmaceutical and manufacturing sectors. The company's dedication to product quality and timely delivery could make it an attractive prospect for venture capitalists looking to enter or expand within these industries. While further details would be required to make a comprehensive assessment, Phil Inter Pharma USA presents an intriguing opportunity for investment consideration.
There is no investment information
No recent news or press coverage available for Phil Inter Pharma USA.
We care about your data, and we'd love to use cookies make your experience better.
